FDA Inspection 1054862 — Soledad O. Lee, MD

Soledad O. Lee, MD — FEI 3006424839

The FDA completed an inspection of Soledad O. Lee, MD on Jun 8, 2018 in La Palma, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 8, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
La Palma, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753121 CFR 312.62(c)Record retention
756021 CFR 312.60FD-1572, protocol compliance